JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3351
Stratasys
SSYS
$750M
| $2.09M | ﹤0.01% |
126,653
+78,078
| +161% | +$1.1M |
2022 Q2
3 quarters
|
|
|
OSH
3352
CALL
DELISTED
Oak Street Health, Inc.
OSH
| $2.09M | ﹤0.01% |
54,100
+50,100
| +1,253% | +$1.62M |
2022 Q4
1 quarter
|
|
|
CORS.U
3353
DELISTED
Corsair Partnering Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CORS.U
| $2.09M | ﹤0.01% |
+205,014
| New | +$2.09M |
2023 Q1
0 quarters
|
|
3354
PUT
Mueller Water Products
MWA
$3.43B
| $2.09M | ﹤0.01% |
150,000
-30,000
| -17% | -$391K |
2022 Q4
1 quarter
|
|
3355
Parsons
PSN
$4.5B
| $2.09M | ﹤0.01% |
46,726
+7,144
| +18% | +$314K |
2019 Q2
15 quarters
|
|
|
SHAP
3356
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $2.09M | ﹤0.01% |
200,000
-140,000
| -41% | -$1.45M |
2022 Q4
1 quarter
|
|
3357
Tennant Co
TNC
$1.16B
| $2.08M | ﹤0.01% |
30,332
+9,024
| +42% | +$612K |
2013 Q2
39 quarters
|
|
3358
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.39B
| $2.08M | ﹤0.01% |
28,380
+2,301
| +9% | +$159K |
2022 Q4
1 quarter
|
|
3359
OrthoPediatrics
KIDS
$593M
| $2.08M | ﹤0.01% |
46,853
+4,285
| +10% | +$189K |
2017 Q4
21 quarters
|
|
3360
PUT
Blackrock
BLK
$167B
| $2.07M | ﹤0.01% |
3,100
-7,900
| -72% | -$5.56M |
2016 Q4
25 quarters
|
|
|
DVAX
3361
DELISTED
Dynavax Technologies
DVAX
| $2.07M | ﹤0.01% |
211,421
+38,374
| +22% | +$410K |
2016 Q3
26 quarters
|
|
3362
CALL
McDonald's
MCD
$164B
| $2.07M | ﹤0.01% |
7,400
-70,900
| -91% | -$19M |
2020 Q2
11 quarters
|
|
3363
iShares International Equity Factor ETF
INTF
$3.71B
| $2.07M | ﹤0.01% |
77,997
+24,223
| +45% | +$631K |
2022 Q4
1 quarter
|
|
3364
Veracyte
VCYT
$3.59B
| $2.07M | ﹤0.01% |
92,654
-292,795
| -76% | -$7.08M |
2017 Q3
22 quarters
|
|
3365
Recursion Pharmaceuticals
RXRX
$2.48B
| $2.06M | ﹤0.01% |
309,514
+136,178
| +79% | +$1.08M |
2021 Q2
7 quarters
|
|
3366
OptimizeRx
OPRX
$166M
| $2.06M | ﹤0.01% |
140,978
-2,117
| -1% | -$35.4K |
2018 Q4
17 quarters
|
|
|
MODN
3367
DELISTED
MODEL N, INC.
MODN
| $2.06M | ﹤0.01% |
61,422
+5,853
| +11% | +$213K |
2016 Q4
25 quarters
|
|
3368
Triumph Financial Inc
TFIN
$1.48B
| $2.05M | ﹤0.01% |
35,321
+4,828
| +16% | +$277K |
2015 Q1
32 quarters
|
|
3369
CALL
Entegris
ENTG
$25.5B
| $2.05M | ﹤0.01% |
25,000
-175,000
| -88% | -$14.2M |
2022 Q3
2 quarters
|
|
|
ZYXI
3370
DELISTED
Zynex
ZYXI
| $2.05M | ﹤0.01% |
170,568
+6,235
| +4% | +$81.5K |
2019 Q1
16 quarters
|
|
3371
EverCommerce
EVCM
$1.64B
| $2.04M | ﹤0.01% |
193,319
-30,140
| -13% | -$291K |
2021 Q3
6 quarters
|
|
3372
flyExclusive
FLYX
$64.7M
| $2.04M | ﹤0.01% |
+200,000
| New | +$2.02M |
2023 Q1
0 quarters
|
|
|
NKGN
3373
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $2.03M | ﹤0.01% |
200,557
-234,433
| -54% | -$2.37M |
2021 Q3
6 quarters
|
|
3374
CALL
CarGurus
CARG
$2.56B
| $2.03M | ﹤0.01% |
+108,600
| New | +$1.85M |
2023 Q1
0 quarters
|
|
3375
CALL
Honeywell
HON
$67.5B
| $2.03M | ﹤0.01% |
11,247
-58,142
| -84% | -$10.9M |
2021 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.